🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 3, randomized, placebo-controlled, double-blind,double-dumm...
Status
Completed
Location
Teva Investigational Site 10851
Start Date
2013-12
Trial ID
NCT02031640
Treatments Being Tested
The study is being conducted to compare the pharmacokinetic (PK) of BDP (an...
Status
Completed
Location
SGS Belgium NV - Clinical Pharmacology Unit
Start Date
2023-04-24
Trial ID
NCT05898984
This study is conducted to assess whether training participants on proper u...
Status
Completed
Location
Teva Investigational Site 34092
Start Date
2014-05-28
Trial ID
NCT02062463
The primary objective of this study is to evaluate the efficacy of beclomet...
Status
Completed
Location
Teva Investigational Site 13415
Start Date
2015-09-30
Trial ID
NCT02513160
Primary Objective To demonstrate that CHF 1535 pMDI is non-inferior to Sym...
Status
Completed
Location
Site 15604 - Anhui Provincial Hospital
Start Date
2018-07-30
Trial ID
NCT03888131
Primary Objective • To demonstrate the superiority of CHF 5993 pressurised...
Status
Completed
Location
Chiesi clinical Trial Site 156031
Start Date
2016-12-14
Trial ID
NCT03197818
Treatments Being Tested
Approximately 480 (120 per group) would need to complete the 6 weeks of tre...
Status
Withdrawn
Location
Multiple Locations
Start Date
2019-02
Trial ID
NCT03834012
The primary objective is to demonstrate the non-inferiority of ciclesonide ...
Status
Completed
Location
Sanofi-Aventis
Start Date
2004-01
Trial ID
NCT00254956
Treatments Being Tested